Discover
INBS
Intelligent Bio Solutions Inc.
2.23
2 x 1.61
2 x 2.86
bid
ask
-
0.06
2.83%
2 @ 04:00 PM
2.24 +0.01 (0.45%)
| Ytd | -76.60% | |
| 1y | -86.73% |
2.20
day range
2.29
2.08
52 week range
24.90
| Open | 2.24 | Prev Close | 2.29 | Low | 2.20 | High | 2.29 | Mkt Cap | 5.33M |
| Vol | 20.14K | Avg Vol | 122.36K | EPS | -11.62 | P/E | N/A | Forward P/E | 3.83 |
| Beta | 4.72 | Short Ratio | 1.25 | Inst. Own | 14.38% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | N/A | 50-d Avg | 2.60 | 200-d Avg | 6.35 | 1yr Est | 12.00 |
Earning
| Date | For | Estimate | Reported | Surprise | surprise % |
|---|---|---|---|---|---|
| 2025-02-14 | 2024-12 | 0 | N/A | N/A | N/A |
| 2024-11-07 | 2024-09 | 0 | -0.7 | N/A | N/A |
| 2024-09-19 | 2024-06 | 0 | N/A | N/A | N/A |
| 2024-05-08 | 2024-03 | 0 | N/A | N/A | N/A |
| 2024-05-08 | 2024-03 | 0 | -1.43 | N/A | N/A |
| 2024-02-09 | 2023-12 | -3.24 | N/A | N/A | N/A |
Upgrade / Downgrade
| Date | Firm | Action | From | To |
|---|
Profile
Intelligent Bio Solutions Inc., a medical technology company, developing rapid, non-invasive testing, and screening solutions. The company operates intelligent fingerprinting drug screening system, a platform to analyze fingerprint sweat analysis to detect drugs abuse. It also operates biosensor platform for clinical chemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities. The company was formerly known as GBS Inc. and changed its name to Intelligent Bio Solutions Inc. in October 2022. Intelligent Bio Solutions Inc. was incorporated in 2016 and is headquartered in New York, New York. The company operates as a subsidiary of Life Science Biosensor Diagnostics Pty Ltd.
Insider Holder
| Date | Name | Relation | Quantity | Description |
|---|---|---|---|---|
| 2024-09-24 | SAKIRIS SPIRO KEVIN | Chief Financial Officer | 53.76K | Stock Award(Grant) |
| 2024-09-24 | SIMEONIDIS HARRY | Chief Executive Officer | 40.41K | Stock Award(Grant) |
| 2023-10-03 | TOWERS CHRISTOPHER | Director | 9.88K | Purchase |
Institution Ownership
| Report Date | Organization | Position | Value | Percentage |
|---|---|---|---|---|
| 2024-09-29 | Alyeska Investment Group, L.p. | 206.20K | 276.31K | 4.70% |
| 2024-06-29 | CVI Holdings, LLC | 79.84K | 106.99K | 1.82% |
| 2024-09-29 | Geode Capital Management, LLC | 22.71K | 30.43K | 0.52% |
| 2024-09-29 | Vanguard Group Inc | 15.49K | 20.75K | 0.35% |
| 2024-09-29 | Adar1 Capital Management, LLC | 5.39K | 7.22K | 0.12% |
| 2024-09-29 | UBS Group AG | 1.55K | 2.08K | 0.04% |
Fund Ownership
| Report Date | Organization | Position | Value | Percentage |
|---|---|---|---|---|
| 2024-10-30 | Fidelity Extended Market Index Fund | 17.64K | 23.64K | 0.40% |
| 2024-09-29 | Vanguard Extended Market Index Fund | 15.49K | 20.75K | 0.35% |
| 2024-10-30 | Fidelity Series Total Market Index Fund | 5.60K | 7.50K | 0.13% |
| 2024-10-30 | Fidelity Total Market Index Fund | 4.10K | 5.49K | 0.09% |
Split
| Split | Date |
|---|---|
| 1 : 10 | 2025-12-16 |
| 1 : 12 | 2024-01-29 |
| 1 : 20 | 2023-02-10 |